The Clinical Significance of HPRT as a Diagnostic and Therapeutic Biomarker for Hematological and Solid Malignancies
An estimated 1,735,350 new cancer diagnosis and 609,640 cancer related deaths are predicted to occur in the United States in 2018. To improve patient prognosis, biomarkers are needed to identify cancer in early stages. When diagnosed at an early stage, cancer is more likely to respond to treatments...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
BYU ScholarsArchive
2018
|
| Subjects: | |
| Online Access: | https://scholarsarchive.byu.edu/etd/7104 https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8104&context=etd |